Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RBC Capital upgrades Anglo American to 'sector perform'

(Sharecast News) - RBC Capital Markets upgraded Anglo American on Tuesday to 'sector perform' from 'underperform' and lifted the price target to 2,310p from 2,200p. The bank downgraded Anglo in January, arguing that much of the good news on restructuring had been delivered and the trickier parts remained, such as De Beers and Woodsmith.

However, it said that a flurry of positive headlines followed as the miner got a good price for its nickel disposal, signed a marketing agreement with Botswana and agreed a joint venture with Codelco.

"This all helped offset consensus downgrades of 11% year-to-date," RBC said.

It said the next key event will be the spin of Anglo Platinum, but that it does not believe it will be a significant re-rating event.

RBC said it was updating its modelling to reflect the forthcoming spin out in June, changing its valuation methodology to reflect the higher proportion of copper earnings.

The bank said that in order to be a buyer, it would need to be more optimistic on the copper or iron ore premiums outlook.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.